Three million euro in funding has been announced for the Clinical Research Facility Galway – a Health Research Board (HRB) centre supporting clinical trials to improve health and care.
The investment is part of a €22 million fund from the HRB for clinical research facilities located at hospital sites and supported by universities.
The Clinical Research Facility Galway is a joint initiative of NUI Galway and Saolta University Health Care Group for the promotion of clinical research and conduct of clinical trials.
The facility brings together clinicians, researchers and academics to focus on studies aimed at understanding diseases and translating the knowledge gained into advances in patient care.
Professor Andrew Smyth, Director of the HRB Clinical Research Facility Galway and Consultant Nephrologist at Galway University Hospitals, said the HRB-CFRG aims to improve patient care and population health through clinical trials, by providing the necessary infrastructure, physical space, facilities, expertise, specialist training and culture.
“This infrastructure funding support from the HRB puts us on the map globally in terms of the ability to manage and execute all stages of clinical trials from conception to conclusion,” said Professor Andrew Smyth.
“At the HRB Clinical Research Facility Galway we have the end-to-end services to guide breakthrough research including first-in-human trials, medical technology/devices, pharmaceuticals, cancer trials and much more.”
He said that their portfolio is one of the most diverse nationally, and they have both the clinical expertise and clinical trial experience to grow their own trials from the ground up.
“The HRB infrastructure funding makes this possible and is essential for growth and expansion of our clinical trials,” he added.
The Clinical Research Facility Galway currently supports 107 clinical trials and investigations.